Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis

PURPOSE: The purpose of this study was to evaluate the efficacy and safety of induction chemotherapy with docetaxel, capecitabine, and cisplatin (DXP) plus bevacizumab (BEV) on initially unresectable locally advanced gastric cancer (LAGC) or paraaortic lymph node (PAN) metastatic gastric cancer (GC)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Res Treat
Päätekijät: Kim, Jwa Hoon, Park, Sook Ryun, Ryu, Min-Hee, Ryoo, Baek-Yeol, Kim, Kyu-pyo, Kim, Beom Su, Yoo, Moon-Won, Yook, Jeong Hwan, Kim, Byung Sik, Kim, Jihun, Byeon, Sun-Ju, Kang, Yoon-Koo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Cancer Association 2018
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5912143/
https://ncbi.nlm.nih.gov/pubmed/28546521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2017.005
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia